Holen Sie sich die Stockscreener-App
6.83
1.94%
0.13
Handel nachbörslich:
6.90
0.07
+1.02%
Schlusskurs vom Vortag:
$6.70
Offen:
$6.7
24-Stunden-Volumen:
1.11M
Relative Volume:
0.47
Marktkapitalisierung:
$759.91M
Einnahmen:
$24.30M
Nettoeinkommen (Verlust:
$-145.57M
KGV:
-5.1353
EPS:
-1.33
Netto-Cashflow:
$-149.17M
1W Leistung:
+0.15%
1M Leistung:
+3.64%
6M Leistung:
+271.20%
1J Leistung:
-36.99%
1-Tages-Spanne:
$6.43
$6.86
1-Wochen-Bereich:
$6.28
$6.86
52-Wochen-Spanne:
$1.03
$11.92
Tango Therapeutics Inc Stock (TNGX) Company Profile
Firmenname
Tango Therapeutics Inc
Sektor
Branche
Telefon
(857) 320-4900
Adresse
201 BROOKLINE AVENUE, BOSTON
Vergleichen Sie TNGX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TNGX
Tango Therapeutics Inc
|
6.83 | 740.99M | 24.30M | -145.57M | -149.17M | -1.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Tango Therapeutics Inc Stock (TNGX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-19 | Eingeleitet | Piper Sandler | Overweight |
| 2024-07-17 | Eingeleitet | Jefferies | Buy |
| 2024-04-04 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-12 | Eingeleitet | Piper Sandler | Overweight |
| 2023-12-08 | Eingeleitet | B. Riley Securities | Buy |
| 2022-10-20 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2021-09-20 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Tango Therapeutics Inc Aktie (TNGX) Neueste Nachrichten
Tango Therapeutics Inc. stock prediction for this weekWeekly Stock Summary & Consistent Income Trade Recommendations - Newser
How institutional ownership impacts Tango Therapeutics Inc. stockJuly 2025 Selloffs & Safe Capital Growth Tips - Newser
Published on: 2025-09-03 05:10:01 - Newser
Can technical indicators confirm Tango Therapeutics Inc.’s reversal2025 Volatility Report & Weekly Hot Stock Watchlists - Newser
When is the best time to exit Tango Therapeutics Inc.Oil Prices & High Return Trade Opportunity Guides - Newser
What does recent volatility data suggest for Tango Therapeutics Inc.Long Setup & Risk Adjusted Swing Trade Ideas - Newser
Will Tango Therapeutics Inc. continue its uptrendEarnings Risk Report & AI Powered Trade Plan Recommendations - Newser
Heatmap analysis for Tango Therapeutics Inc. and competitorsQuarterly Market Summary & Risk Controlled Daily Trade Plans - Newser
What is Tango Therapeutics Inc.’s market positionRate Cut & Weekly Stock Breakout Alerts - khodrobank.com
How to track smart money flows in Tango Therapeutics Inc.Market Growth Summary & Free Low Drawdown Momentum Trade Ideas - Newser
Is Tango Therapeutics Inc. stock a value trap2025 Key Highlights & Low Volatility Stock Suggestions - khodrobank.com
Combining machine learning predictions for Tango Therapeutics Inc.Exit Point & Weekly High Return Opportunities - Newser
Visualizing Tango Therapeutics Inc. stock with heatmapsTrade Analysis Report & Daily Growth Stock Investment Tips - Newser
Can Tango Therapeutics Inc. be the next market leaderExit Point & Reliable Price Breakout Signals - khodrobank.com
Analyzing recovery setups for Tango Therapeutics Inc. investorsLong Setup & Low Risk High Win Rate Picks - Newser
Automated trading signals detected on Tango Therapeutics Inc.Earnings Recap Summary & Real-Time Volume Triggers - Newser
Real time breakdown of Tango Therapeutics Inc. stock performance2025 Volume Leaders & Technical Analysis for Trade Confirmation - Newser
Can Tango Therapeutics Inc. be recession proofPortfolio Value Summary & AI Driven Price Forecasts - khodrobank.com
Will Tango Therapeutics Inc. stock go up soonEarnings Beat & Daily Market Momentum Tracking - Newser
Chart based exit strategy for Tango Therapeutics Inc.Quarterly Profit Summary & Consistent Growth Equity Picks - Newser
Is Tango Therapeutics Inc. forming a bottoming base2025 Volume Leaders & Real-Time Volume Analysis - Newser
Using flow based indicators on Tango Therapeutics Inc.2025 Fundamental Recap & Free Fast Entry Momentum Trade Alerts - Newser
What data driven models say about Tango Therapeutics Inc.’s future2025 Stock Rankings & Daily Stock Momentum Reports - Newser
Will earnings trigger a reversal in Tango Therapeutics Inc.Portfolio Return Report & Free Expert Approved Momentum Trade Ideas - Newser
Tango Therapeutics Inc. stock daily chart insightsMarket Growth Review & Free Reliable Trade Execution Plans - Newser
What’s Tango Therapeutics Inc.’s historical return2025 Key Highlights & Entry Point Confirmation Signals - khodrobank.com
Can Tango Therapeutics Inc. stock recover from recent declineJuly 2025 EndofMonth & Risk Controlled Stock Alerts - Newser
Tango Therapeutics Inc. stock trend forecastTrade Entry Summary & High Conviction Buy Zone Picks - Newser
Is Tango Therapeutics Inc. stock bottoming outMarket Performance Report & Daily Stock Momentum Reports - Newser
Will Tango Therapeutics Inc. Benefit From Broader Market BounceQuarterly Market Review & Daily Entry Point Trade Alerts - beatles.ru
Order flow analysis tools used on Tango Therapeutics Inc.Quarterly Risk Review & High Win Rate Trade Alerts - Newser
Full technical analysis of Tango Therapeutics Inc. stock2025 Dividend Review & Fast Gaining Stock Strategy Reports - Newser
What Fibonacci levels say about Tango Therapeutics Inc. rebound2025 Geopolitical Influence & AI Driven Price Predictions - Newser
Analyzing drawdowns of Tango Therapeutics Inc. with statistical tools2025 Short Interest & Community Trade Idea Sharing - Newser
Published on: 2025-08-31 00:28:08 - Newser
Risk adjusted return profile for Tango Therapeutics Inc. analyzedEarnings Performance Report & AI Driven Stock Movement Reports - Newser
Statistical indicators supporting Tango Therapeutics Inc.’s strengthJuly 2025 Volume & Smart Allocation Stock Reports - Newser
Can Tango Therapeutics Inc. rally from current levelsJuly 2025 Highlights & Verified Entry Point Signals - Newser
Finanzdaten der Tango Therapeutics Inc-Aktie (TNGX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):